Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 56:96-106, 2007
DOI: 10.2337/db05-1073
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arnaud-Dabernat, S.
Right arrow Articles by Sarvetnick, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arnaud-Dabernat, S.
Right arrow Articles by Sarvetnick, N.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

FGFR3 Is a Negative Regulator of the Expansion of Pancreatic Epithelial Cells

Sandrine Arnaud-Dabernat1,2, Marcie Kritzik1, Ayse G. Kayali1, You-Qing Zhang1, Guoxun Liu1, Cory Ungles1, and Nora Sarvetnick1

1 Department of Immunology, The Scripps Research Institute, La Jolla, California
2 Laboratoire de la Biologie de la Differenciation et du Developpement, University Victor Segalen Bordeaux 2, Bordeaux Cedex, France

Address correspondence and reprint requests to Nora Sarvetnick, The Scripps Research Institute, Department of Immunology, IMM23, 10550 North Torrey Pines Rd., La Jolla, CA 92037. E-mail: noras{at}scripps.edu

Abbreviations: ASU, arbitrary surface units; BrdU, 5-bromo-2-deoxyuridine; ERK, extracellular signal–related kinase; FGF, fibroblast growth factor; FGFR, FGF receptor; PDX-1, pancreatic duodenal homeobox-1; TUNEL, transferase-mediated dUTP nick-end labeling

Fibroblast growth factors (FGFs) and their receptors (FGFRs) are key signaling molecules for pancreas development. Although FGFR3 is a crucial developmental gene, acting as a negative regulator of bone formation, its participation remains unexplored in pancreatic organogenesis. We found that FGFR3 was expressed in the epithelia in both mouse embryonic and adult regenerating pancreata but was absent in normal adult islets. In FGFR3 knockout mice, we observed an increase in the proliferation of epithelial cells in neonates, leading to a marked increase in islet areas in adults. In vitro studies showed that FGF9 is a very potent ligand for FGFR3 and activates extracellular signal–related kinases (ERKs) in pancreatic cell lines. Moreover, FGFR3 blockade or FGFR3 deficiency led to increased proliferation of pancreatic epithelial cells in vivo. This was accompanied by an increase in the proportion of potential islet progenitor cells. Thus, our results show that FGFR3 signaling inhibits the expansion of the immature pancreatic epithelium. Consequently, this study suggests that FGFR3 participates in regulating pancreatic growth during the emergence of mature islet cells.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
F. C. Schuit and D. J. Drucker
{beta}-Cell Replication by Loosening the Brakes of Glucagon-Like Peptide-1 Receptor Signaling
Diabetes, March 1, 2008; 57(3): 529 - 531.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.